Literature DB >> 11818695

The inflammatory cascade in acute ischemic renal failure.

Mark D Okusa1.   

Abstract

The pathogenesis of human acute ischemic renal failure is complex. Studies in animals have revealed a number of factors that could contribute to the injury associated with acute ischemic renal failure. Despite these discoveries, we have yet to devise a therapeutic regimen that will ameliorate or prevent acute renal failure in humans. Nevertheless we have made great strides in understanding mechanisms that contribute to acute ischemic renal failure. An important component is the contribution of the inflammatory cascade brought about by tissue reperfusion following an ischemic period. This review summarizes recent studies that implicate the inflammatory cells in the development of renal injury associated with acute ischemic renal failure. Because of the complex overlapping pathways involved in the inflammatory cascade, blocking single molecules is unlikely to be successful in reducing renal injury. Rather broadly abrogating the inflammatory cascade is likely to yield the greatest success in the treatment and prevention of acute ischemic renal failure. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11818695     DOI: 10.1159/000049032

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  65 in total

1.  Sepsis and AKI: more complex than just a simple question of chicken and egg.

Authors:  P M Honoré; R Jacobs; W Boer; O Joannes-Boyau
Journal:  Intensive Care Med       Date:  2010-12-09       Impact factor: 17.440

2.  Overexpression of p18INK⁴C in LLC-PK1 cells increases resistance to cisplatin-induced apoptosis.

Authors:  Yi Zhang; Li Yuan; Lili Fu; Chunyan Liu; Dongmei Liu; Changlin Mei
Journal:  Pediatr Nephrol       Date:  2011-04-15       Impact factor: 3.714

Review 3.  Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

Authors:  S-K Jo; A Bajwa; A S Awad; K R Lynch; M D Okusa
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

4.  Cytokine-induced F-actin reorganization in endothelial cells involves RhoA activation.

Authors:  Silvia B Campos; Sharon L Ashworth; Sarah Wean; Melanie Hosford; Ruben M Sandoval; Mark A Hallett; Simon J Atkinson; Bruce A Molitoris
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

Review 5.  Slit2-Robo signaling in inflammation and kidney injury.

Authors:  Swasti Chaturvedi; Lisa A Robinson
Journal:  Pediatr Nephrol       Date:  2014-04-29       Impact factor: 3.714

Review 6.  Renal repair: role of bone marrow stem cells.

Authors:  Fangming Lin
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

Review 7.  Cell-based strategies for the treatment of kidney dysfunction: a review.

Authors:  Christopher J Pino; Alexander S Yevzlin; James Tumlin; H David Humes
Journal:  Blood Purif       Date:  2012-10-24       Impact factor: 2.614

8.  Thyroxine prevents reoxygenation injury in isolated proximal tubule cells.

Authors:  Elif Erkan; Abdullah Sakarcan; Gonca Haklar; Suha Yalcin
Journal:  Pediatr Nephrol       Date:  2003-05-07       Impact factor: 3.714

9.  Cellular repressor of E1A stimulated genes enhances endothelial monolayer integrity.

Authors:  Yan Duan; Shaowei Liu; Jie Tao; Yang You; Guitang Yang; Chenghui Yan; Yaling Han
Journal:  Mol Biol Rep       Date:  2013-04-12       Impact factor: 2.316

10.  Targeting sphingosine 1 phosphate receptor type 1 receptors in acute kidney injury.

Authors:  Mark D Okusa; Kevin R Lynch
Journal:  Drug Discov Today Dis Mech       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.